AbbVie-Cerevel gets second request from US FTC
MLex Summary: AbbVie's proposed acquisition of Cerevel Therapeutics received a second request from the US Federal Trade Commission today, according to a securities disclosure by Cerevel. "The Company continues to expect...To view the full article, register now.
Already a subscriber? Click here to view full article